🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the percentage of participants wit...
Status
Completed
Location
Pacific Cancer Medical Center
Start Date
2018-03-13
Trial ID
NCT03439293
Treatments Being Tested
The main objective of this study is to evaluate the minimal residual diseas...
Status
Unknown
Location
CHU Bordeaux
Start Date
2018-12-31
Trial ID
NCT03669445
Treatments Being Tested
This is a multicenter, randomized, open-label, Phase 3 study comparing the ...
Status
Completed
Location
Local Institution - 109
Start Date
2019-04-16
Trial ID
NCT03651128
This phase II trial studies how well ixazomib citrate, lenalidomide, dexame...
Status
Completed
Location
Mayo Clinic
Start Date
2017-04-20
Trial ID
NCT03012880
A randomized Phase II clinical trial will be conducted to assess the impact...
Status
Active Not Recruiting
Location
Northern Light Eastern Maine Medical Center
Start Date
2020-10-21
Trial ID
NCT04009109
Treatments Being Tested
Multiple myeloma is an incurable hematological malignancy that affects olde...
Status
Terminated
Location
CHU CAEN Dept of Hematology
Start Date
2019-02-07
Trial ID
NCT03757221
Treatments Being Tested
The purpose of this study is assess safety, safest dose, and effectiveness ...
Status
Active Not Recruiting
Location
Boston Medical Center
Start Date
2022-10-26
Trial ID
NCT05451771
This study will independently assess the efficacy and safety of 11 combinat...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2015-10
Trial ID
NCT02343042
This phase II trial studies how well ixazomib citrate works in treating pat...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2012-01-31
Trial ID
NCT01415882
Treatments Being Tested
The purpose of this study is to determine the overall response rate of pati...
Status
Terminated
Location
UCSD Moores Cancer Center
Start Date
2018-10-17
Trial ID
NCT03590652